Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (18968)	2/20/1999 8:31:00 PM
From: DAVID	Respond to of 23519

<<Wilson gets head out of ass and signs domestic partner??????????>> That's OK with me as long as he doesn't use his foot or thumb as a replacement. DAVID

To: VLAD who wrote (18968)	2/20/1999 8:38:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

DaiS, astra.com astra.com Correct my math if it is wrong: Astra had 1998 MUSE sales totaling 86 million Swedish Kronars 86M Kronars equals about 6.6M lbs Sterling 1 pound Sterling = $1.66 US So Astra had 1998 MUSE sales of approximately $11M. Not too shoddy considering that England was the only country Astra sold to until the third quarter 1998 when Astra launched MUSE in Sweden, Switzerland, Brazil and Argentina. If Astra could make $11M marketing to only 3 European countries, they should be able to show strong sales as they launch MUSE in the other 12 EU countries. Janssen actually controls most of the technically European market since they hold marketing rights to the old Eastern block nations and the old Soviet Union countries and Turkey. Here is a list of the non EU countries composing Europe and their respective populations: Country/population in thousands 1)Russia/146,861 2)Turkey/64,568 3)Ukraine/50,125 4)Poland/38,607 5)Romania/22,396 6)Serbia-Montenagro/10,526 7)Belarus/10,409 8)Czech Republic/10,286 9)Hungary/10,208 10)Switzerland/7,260-already launched-in Astra's teritory 11)Slovakia/5,393 12)Maldova/4,458 13)Croatia/4,672 14)Norway/4,420 15)Turkmenistan/4,298 16)Lithuania/3,600 17)Bosnia&Herzegovina/3,366 18)Albania/3,331 19)Latvia/2,385 20)Macedonia/2,009 21)Slovenia/1,972 22)Cypress/749 23)Malta/379 24)Andora/65 25)Monaco/32 26)Liechtenstein/32 27)Gilbraltar/29 28)SanMarino/25 --------------------- Total Non European Union population = 412,461,000 Total European Union population = 373,815,000 Total Europe population = 786,276

To: VLAD who wrote (18968)	2/20/1999 9:30:00 PM
From: KHS	Read Replies (3) \| Respond to of 23519

VLAD, I have considering buying more shares. Like others, I was buying at 6, 5, even 2 1/2 last year. If I believe the fundamentals are close to where they were last Fall, I should buy. In fact, the fundamentals may even be better. #1 Not running out of cash #2 Viagra hype decreasing #3 More public awareness concerning proper usage of Viagra #4 4 to 5 months closer to something (partner/buyout) Why am I holding back? Have some cash, and would even be willing to cash in portion of another holding to buy more. L. Wilson (lack of faith), could he drive this thing into the ground? Maybe a discussion of what L. Wilson may do that would jeopordize $2 level. What could go wrong from here? Any help would be appreciated.

To: VLAD who wrote (18968)	2/21/1999 12:32:00 PM
From: BigKNY3	Read Replies (12) \| Respond to of 23519

Vlad: <<This coming week should be revealing:1)February 24--short interest numbers published 2)February 24--exactly 3 months since the last Viagra body count released by the FDA. New tally due. Now we include a lot of new patients as new international markets have opened. >> V-man: Two questions for you to ponder: Can you document that any negative Viagra news has ever had more than a one day effect on the price of VVUS? Assume that there was never any negative Viagra reports published in the news, do you think the price of VVUS would be lower than it is today? Bottom-line: As first posted on March 15, 1998 (pre-Viagra approval), I believe the price of VVUS is still primarily related to the level of US MUSE Rx specification and investor perception of its future direction. Message 3715970 BigKNY3